[333 Pages Report] The global radiation therapy software market is predicted to reach US$ 354.9 million in 2022. Based on the report, sales of radiation therapy software are expected to grow at a CAGR of 8.20% to reach a market estimate of US$ 847.9 million by 2032.
One of the foremost factors resulting in the increasing adoption of radiation therapy software across the world is the rising prevalence of cancer. Radiation therapy encourages the use of high-energy particles or waves to kill cancerous cells. Radiation therapy has become additionally complicated in its procedures; novel techniques are invented for treating patients. Several features are being continuously added to enhance the conventional application, with the similar end goal of the treatment of cancer growth.
| Report Attribute | Details |
|---|---|
| Radiation Therapy Software Market Value (2022) | US$ 354.9 Million |
| Radiation Therapy Software Market Anticipated Value (2032) | US$ 847.9 Million |
| Radiation Therapy Software Projected Growth Rate (2022 to 2032) | 8.20 % |
The demand for radiation therapy software is soaring owing to the increasing availability of oncology treatment planning software with enhanced features is the crucial factor intensifying the growth of the market. This, coupled with increasing cancer cases and the growing benefits of the radiation therapy software market over the practice of conventional record maintenance, are key factors responsible for the growth of the radiation therapy software market.
However, there is a need for healthcare authorities to indulge in therapy treatment planning and render the most efficient therapy and precise planning of treatment to the patients. An overview of radiation therapy software has removed the number of errors that have been known to occur during the process of radiation therapy delivery.
Presently the radiation therapy software that is available in the market is meant to deliver consistent and pervasive access to patient information and disease history and enable the use of complicated techniques such as Intensity Modulated Radiation Therapy (IMRT) for treating various symptoms to upload treatment parameters automatically, therefore enhancing the treatment accuracy and efficiency.
The global radiation therapy software market is anticipated to grow in terms of value due to its competence to monitor radiation doses and ascertain and deliver disease diagnosis-specific data to acquire critical responses to the treatment/treatment and prolonged clinical outcomes.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
GLOBOCAN 2020 says that in 2020, there were nearly 19.29 million new cancer cases across the world, and this figure is anticipated to reach 28.4 million by the end of 2040. Globally, the prevalence of cancer is projected to be 50.6 million. This is a five-year prevalence, meaning the total number of individuals living with cancer in the past five years. The alarmingly increasing rate of cancer is resulting in the demand for radiation therapy software and eventually promoting the growth of the market.
Radiation therapy planning and delivery procedure enable smooth incorporation of computerized data sources, computer control systems, software tools, and computer control systems, therefore enabling natural workflow and clinicians to collect patients’ information from diseases diagnosis through treatment and follow-up to deliver the most efficient treatment plans and conduct quality assurance procedures safely and effectively.
The increasing need for effective and integrated workflow platforms to ensure efficient and precise informed clinical decision-making coupled with growing cases of cancer together are likely to propel the global radiation therapy software market during the forecast period.
Moreover, integrated radiation therapy software decreases transcription errors and unwanted patient wait times by removing the data entry errors. Frequent updates in the existing software are expected to lead to the growing market value of radiation therapy software during the forecast years.
Application Insights
In 2021, the radiation therapy software market's largest share was expected to go to patients with prostate cancer. One of the most cutting-edge ways to treat prostate cancer is with prostatic brachytherapy. Prostate cancer patients can benefit from LDR or HDR brachytherapy. The treatment of high-risk prostate cancer with brachytherapy is becoming more common worldwide. It can be used on its own or in conjunction with other treatments like hormone therapy or external beam radiation therapy (EBRT). LDR brachytherapy is as effective as prostatectomy or EBRT because it delivers low doses of radiation and protects healthy tissues around the tumour. In addition, because the radioactive seeds implanted in the prostate move with it, brachytherapy does not require any monitoring of the gland's movement.
Globally, the healthcare IT market is anticipated to boom in the future. The healthcare IT industry takes exception to numerous industries, this includes healthcare, medical technology, digital health, medical devices, and healthcare. This industry is said to disturb the conventional healthcare delivery model and research systems by using modern and enhanced technologies. This is expected to change the radiation therapy software market outlook.
End-User
Hospital is expected to account for the biggest market share of the global radiation therapy software market during the forecast period. The growing adoption of radiation therapy software at hospitals is owing to a greater number of information generated during treatment and diagnosis of cancer and a considerable number of patient visits/submissions each year across the world. Growing government initiatives focusing on equipping hospitals with the latest and advanced systems are a few of the factors accountable for the growth of this segment.
Lack of skilled technicians and clinicians, and unexpected errors in the software program, namely bugs, can restrict the growth of the global radiation therapy software market. Underdeveloped economies having a lack healthcare infrastructure is likely to disrupt the growing market during the forecast period.
Principal Consultant
North America is accountable for 38% market share in the global radiation therapy software market. This region’s market is said to maintain its market position during the forecast period owing to increased and heavy dependency of clinicians on advanced disease platforms.
The region makes use of advanced services because there is a growing number of patients suffering from cancer every year. This has led to expanding radiation therapy software market value and therefore growing demand for radiation therapy software. Accessibility to advanced healthcare infrastructure assists in maintaining a larger radiation therapy software market share in North America.
Europe radiation therapy software market to hold 31% share in the global market. This region is accountable for the second largest radiation therapy software market share after North America owing to increasing awareness pertaining to the treatment demands. Accessibility to more accurate and efficient cancer treatments, increasing research and development activities, and partnerships among manufacturers are predicted to boost the radiation therapy software market in Europe.
In Europe, Germany is anticipated to progress at a higher CAGR during the forecast period. This is because healthcare providers are focusing more on radiotherapy patient positioning, as this technique assists patients with multiple radiations in lesser sessions, therefore saving on money and time.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The start-up ecosystem in the radiation therapy software market is heavily influenced by the latest developments in the industry.
In February 2017, Johnson & Johnson innovation led a $25 million Series A in Fusion Pharmaceuticals, which is a targeted cancer radiotherapeutic start-up. The funding is expected to support phase 1A of Fusion’s antibody-targeted radiotherapy, beyond which the company plans to run a proof-of-concept trial in non-small cell lung cancer.
In July 2022, RefleXion Medical took on a $125 Million loan ahead of the FDA decision on radiotherapy technology. The company is all-in on its biology-guided radiotherapy (BgRT) system. The start-up has more than doubled its existing debt to prepare for the technology’s commercial launch.
Some of the key players in the radiation therapy software market are Koninklijke Philips, N.V Elekta AB, Siemens Healthcare GmbH Brainlab AG, Standard Imaging Inc, RAYSEARCH LABORATORIES and Varian Medical Systems, Inc.
Market players have adopted strategies such as product approvals, product launches, market initiatives, and mergers and acquisitions. In June 2021, Royal Philips, and Elekta had an agreement to strengthen their existing strategic partnership to improve complete and customized cancer care through precision oncology solutions. The broadened alliance develops on the two companies’ successful cooperation in the fast-developing field of magnetic resonance (MR) guided adaptive radiation therapy. Across deeper cross-portfolio collaboration, Philips and Elekta are forecasted to employ their corresponding capabilities to further improve patient care.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 8.20% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2016-2021 |
| Forecast Period | 2022-2032 |
| Quantitative Units | Revenue in US$ Million and CAGR from 2022-2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
The growth outlook for the radiation therapy software market is predicted to advance at a CAGR of 8.20% from 2022 to 2032.
The North American region is anticipated to lead the radiation therapy software market during the forecast period.
The radiation therapy software market is likely to hold a valuation of US$ 847.9 million by 2032.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Radiation Therapy Software Market Analysis 2017-2021 and Forecast, 2022-2032 4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Radiation Therapy Software Market Analysis 2017-2021 and Forecast 2022-2032, By Deployment 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Mn) Analysis By Deployment, 2017-2021 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Deployment, 2022-2032 5.3.1. Cloud Based Platform 5.3.2. On Premises 5.4. Y-o-Y Growth Trend Analysis By Deployment, 2017-2021 5.5. Absolute $ Opportunity Analysis By Deployment, 2022-2032 6. Global Radiation Therapy Software Market Analysis 2017-2021 and Forecast 2022-2032, By End User 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032 6.3.1. Hospitals 6.3.2. Ambulatory Surgical Centers 6.3.3. Specialty Cancer Centers 6.3.4. Cancer Research Institutes 6.3.5. Others 6.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021 6.5. Absolute $ Opportunity Analysis By End User, 2022-2032 7. Global Radiation Therapy Software Market Analysis 2017-2021 and Forecast 2022-2032, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021 7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032 7.3.1. North America 7.3.2. Latin America 7.3.3. Europe 7.3.4. Asia Pacific 7.3.5. MEA 7.4. Market Attractiveness Analysis By Region 8. North America Radiation Therapy Software Market Analysis 2017-2021 and Forecast 2022-2032, By Country 8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 8.2.1. By Country 8.2.1.1. US 8.2.1.2. Canada 8.2.2. By Deployment 8.2.3. By End User 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Deployment 8.3.3. By End User 8.4. Key Takeaways 9. Latin America Radiation Therapy Software Market Analysis 2017-2021 and Forecast 2022-2032, By Country 9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Deployment 9.2.3. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Deployment 9.3.3. By End User 9.4. Key Takeaways 10. Europe Radiation Therapy Software Market Analysis 2017-2021 and Forecast 2022-2032, By Country 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. U.K. 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Europe 10.2.2. By Deployment 10.2.3. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Deployment 10.3.3. By End User 10.4. Key Takeaways 11. Asia Pacific Radiation Therapy Software Market Analysis 2017-2021 and Forecast 2022-2032, By Country 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 11.2.1. By Country 11.2.1.1. China 11.2.1.2. Japan 11.2.1.3. South Korea 11.2.1.4. Rest of Asia Pacific 11.2.2. By Deployment 11.2.3. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Deployment 11.3.3. By End User 11.4. Key Takeaways 12. MEA Radiation Therapy Software Market Analysis 2017-2021 and Forecast 2022-2032, By Country 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 12.2.1. By Country 12.2.1.1. GCC Countries 12.2.1.2. South Africa 12.2.1.3. Israel 12.2.1.4. Rest of MEA 12.2.2. By Deployment 12.2.3. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Deployment 12.3.3. By End User 12.4. Key Takeaways 13. Key Countries Radiation Therapy Software Market Analysis 13.1. US 13.1.1. Pricing Analysis 13.1.2. Market Share Analysis, 2021 13.1.2.1. By Deployment 13.1.2.2. By End User 13.2. Canada 13.2.1. Pricing Analysis 13.2.2. Market Share Analysis, 2021 13.2.2.1. By Deployment 13.2.2.2. By End User 13.3. Brazil 13.3.1. Pricing Analysis 13.3.2. Market Share Analysis, 2021 13.3.2.1. By Deployment 13.3.2.2. By End User 13.4. Mexico 13.4.1. Pricing Analysis 13.4.2. Market Share Analysis, 2021 13.4.2.1. By Deployment 13.4.2.2. By End User 13.5. Germany 13.5.1. Pricing Analysis 13.5.2. Market Share Analysis, 2021 13.5.2.1. By Deployment 13.5.2.2. By End User 13.6. U.K. 13.6.1. Pricing Analysis 13.6.2. Market Share Analysis, 2021 13.6.2.1. By Deployment 13.6.2.2. By End User 13.7. France 13.7.1. Pricing Analysis 13.7.2. Market Share Analysis, 2021 13.7.2.1. By Deployment 13.7.2.2. By End User 13.8. Spain 13.8.1. Pricing Analysis 13.8.2. Market Share Analysis, 2021 13.8.2.1. By Deployment 13.8.2.2. By End User 13.9. Italy 13.9.1. Pricing Analysis 13.9.2. Market Share Analysis, 2021 13.9.2.1. By Deployment 13.9.2.2. By End User 13.10. China 13.10.1. Pricing Analysis 13.10.2. Market Share Analysis, 2021 13.10.2.1. By Deployment 13.10.2.2. By End User 13.11. Japan 13.11.1. Pricing Analysis 13.11.2. Market Share Analysis, 2021 13.11.2.1. By Deployment 13.11.2.2. By End User 13.12. South Korea 13.12.1. Pricing Analysis 13.12.2. Market Share Analysis, 2021 13.12.2.1. By Deployment 13.12.2.2. By End User 13.13. GCC Countries 13.13.1. Pricing Analysis 13.13.2. Market Share Analysis, 2021 13.13.2.1. By Deployment 13.13.2.2. By End User 13.14. South Africa 13.14.1. Pricing Analysis 13.14.2. Market Share Analysis, 2021 13.14.2.1. By Deployment 13.14.2.2. By End User 13.15. Israel 13.15.1. Pricing Analysis 13.15.2. Market Share Analysis, 2021 13.15.2.1. By Deployment 13.15.2.2. By End User 14. Market Structure Analysis 14.1. Competition Dashboard 14.2. Competition Benchmarking 14.3. Market Share Analysis of Top Players 14.3.1. By Regional 14.3.2. By Deployment 14.3.3. By End User 15. Competition Analysis 15.1. Competition Deep Dive 15.1.1. Koninklijke Philips 15.1.1.1. Overview 15.1.1.2. Product Portfolio 15.1.1.3. Profitability by Market Segments 15.1.1.4. Sales Footprint 15.1.1.5. Strategy Overview 15.1.1.5.1. Marketing Strategy 15.1.2. Elekta AB 15.1.2.1. Overview 15.1.2.2. Product Portfolio 15.1.2.3. Profitability by Market Segments 15.1.2.4. Sales Footprint 15.1.2.5. Strategy Overview 15.1.2.5.1. Marketing Strategy 15.1.3. Siemens Healthcare GmbH 15.1.3.1. Overview 15.1.3.2. Product Portfolio 15.1.3.3. Profitability by Market Segments 15.1.3.4. Sales Footprint 15.1.3.5. Strategy Overview 15.1.3.5.1. Marketing Strategy 15.1.4. Brainlab AG 15.1.4.1. Overview 15.1.4.2. Product Portfolio 15.1.4.3. Profitability by Market Segments 15.1.4.4. Sales Footprint 15.1.4.5. Strategy Overview 15.1.4.5.1. Marketing Strategy 15.1.5. Standard Imaging Inc 15.1.5.1. Overview 15.1.5.2. Product Portfolio 15.1.5.3. Profitability by Market Segments 15.1.5.4. Sales Footprint 15.1.5.5. Strategy Overview 15.1.5.5.1. Marketing Strategy 15.1.6. Raysearch Laboratories 15.1.6.1. Overview 15.1.6.2. Product Portfolio 15.1.6.3. Profitability by Market Segments 15.1.6.4. Sales Footprint 15.1.6.5. Strategy Overview 15.1.6.5.1. Marketing Strategy 15.1.7. Varian Medical Systems, Inc. 15.1.7.1. Overview 15.1.7.2. Product Portfolio 15.1.7.3. Profitability by Market Segments 15.1.7.4. Sales Footprint 15.1.7.5. Strategy Overview 15.1.7.5.1. Marketing Strategy 15.1.8. Radyalis 15.1.8.1. Overview 15.1.8.2. Product Portfolio 15.1.8.3. Profitability by Market Segments 15.1.8.4. Sales Footprint 15.1.8.5. Strategy Overview 15.1.8.5.1. Marketing Strategy 15.1.9. Lifeline Software 15.1.9.1. Overview 15.1.9.2. Product Portfolio 15.1.9.3. Profitability by Market Segments 15.1.9.4. Sales Footprint 15.1.9.5. Strategy Overview 15.1.9.5.1. Marketing Strategy 15.1.10. IBA Group 15.1.10.1. Overview 15.1.10.2. Product Portfolio 15.1.10.3. Profitability by Market Segments 15.1.10.4. Sales Footprint 15.1.10.5. Strategy Overview 15.1.10.5.1. Marketing Strategy 15.1.11. Medron Medical Systems 15.1.11.1. Overview 15.1.11.2. Product Portfolio 15.1.11.3. Profitability by Market Segments 15.1.11.4. Sales Footprint 15.1.11.5. Strategy Overview 15.1.11.5.1. Marketing Strategy 15.1.12. Mirada Medical 15.1.12.1. Overview 15.1.12.2. Product Portfolio 15.1.12.3. Profitability by Market Segments 15.1.12.4. Sales Footprint 15.1.12.5. Strategy Overview 15.1.12.5.1. Marketing Strategy 15.1.13. DOSIsoft 15.1.13.1. Overview 15.1.13.2. Product Portfolio 15.1.13.3. Profitability by Market Segments 15.1.13.4. Sales Footprint 15.1.13.5. Strategy Overview 15.1.13.5.1. Marketing Strategy 16. Assumptions & Acronyms Used 17. Research Methodology
Explore Healthcare Insights
View Reports
Radiation Therapy Software Market
